Skip to contentV
Vaxart, Inc.
V
VXRTVaxart, Inc. Q2 2022 · 10-Q
Revenue$0.00$0.00−100.0% vs Q2 2021 Net Income-$29.43M-$29.43MN/M vs Q2 2021 EPS, diluted—
Operating Income-$29,247,000N/M Operating Cash Flowderived-$25,899,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
Free Cash Flowderived-$28,225,000N/M ended Jun 30, 2022 · filed Aug 8, 2022 · 39 d after period end